1 - 25 of 351 results for author:"Schmidt A." in Literature citations
Results Customize
› Repeat search in UniProtKB (716)
| Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Schmidt A.G., Xu H., Khan A.R., O'Donnell T., Khurana S., King L.R., Manischewitz J., Golding H., Suphaphiphat P., Carfi A. et al. Proc. Natl. Acad. Sci. U.S.A. 110:264-269(2013) · UniProtKB (11) |
| Identification of a DNA methylation-independent imprinting control region at the Arabidopsis MEDEA locus. Wohrmann H.J., Gagliardini V., Raissig M.T., Wehrle W., Arand J., Schmidt A., Tierling S., Page D.R., Schob H., Walter J. et al. Genes Dev. 26:1837-1850(2012) · Mapped (1) |
| Tramps, narrow endemics and morphologically cryptic species in the epiphyllous liverwort Diplasiolejeunea. Dong S., Schafer-Verwimp A., Meinecke P., Feldberg K., Bombosch A., Pocs T., Schmidt A.R., Reitner J., Schneider H., Heinrichs J. Mol. Phylogenet. Evol. 65:582-594(2012) · UniProtKB (82) |
| Restricted expression of Neuroglobin in the mouse retina and co-localization with Melanopsin and Tyrosine Hydroxylase. Hundahl C.A., Fahrenkrug J., Luuk H., Hay-Schmidt A., Hannibal J. Biochem. Biophys. Res. Commun. 425:100-106(2012) · Mapped (4) |
| Two faces of the same coin: benign familial infantile seizures and paroxysmal kinesigenic dyskinesia caused by PRRT2 mutations. Schmidt A., Kumar K.R., Redyk K., Grunewald A., Leben M., Munchau A., Sue C.M., Hagenah J., Hartmann H., Lohmann K. et al. Arch. Neurol. 69:668-670(2012) · Mapped (1) |
| GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening. de Aguiar E.S., Giacomazzi J., Schmidt A.V., Bock H., Saraiva-Pereira M.L., Schuler-Faccini L., Duarte Filho D., dos Santos P.A., Giugliani R., Caleffi M. et al. Rev Bras Epidemiol 15:246-255(2012) · Mapped (14) |
| Effect of permanent middle cerebral artery occlusion on Cytoglobin expression in the mouse brain. Raida Z., Reimets R., Hay-Schmidt A., Hundahl C.A. Biochem. Biophys. Res. Commun. 424:274-278(2012) · Mapped (1) |
| The protease-activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression. Zampatis D.E., Rutz C., Furkert J., Schmidt A., Wustenhagen D., Kubick S., Tsopanoglou N.E., Schulein R. FEBS Lett. 586:2351-2359(2012) · Mapped (7) |
| Cutting edge: IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo. Zou T., Satake A., Corbo-Rodgers E., Schmidt A.M., Farrar M.A., Maltzman J.S., Kambayashi T. J. Immunol. 189:28-32(2012) · Mapped (27) |
| RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. Akirav E.M., Preston-Hurlburt P., Garyu J., Henegariu O., Clynes R., Schmidt A.M., Herold K.C. PLoS ONE 7:e34698-e34698(2012) · Mapped (36) |
| Structural insights into interaction between mammalian methionine sulfoxide reductase B1 and thioredoxin. Dobrovolska O., Rychkov G., Shumilina E., Nerinovski K., Schmidt A., Shabalin K., Yakimov A., Dikiy A. J. Biomed. Biotechnol. 2012:586539-586539(2012) · Mapped (4) |
| Circadian behaviour in neuroglobin deficient mice. Hundahl C.A., Fahrenkrug J., Hay-Schmidt A., Georg B., Faltoft B., Hannibal J. PLoS ONE 7:e34462-e34462(2012) · Mapped (4) |
| Cell-autonomous role of TGFbeta and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD. Sawamukai N., Satake A., Schmidt A.M., Lamborn I.T., Ojha P., Tanaka Y., Kambayashi T. Blood 119:5575-5583(2012) · Mapped (12) |
| RAGE binds C1q and enhances C1q-mediated phagocytosis. Ma W., Rai V., Hudson B.I., Song F., Schmidt A.M., Barile G.R. Cell. Immunol. 274:72-82(2012) · Mapped (36) |
| New clusters of arsenite oxidase and unusual bacterial groups in enrichments from arsenic-contaminated soil. Sultana M., Vogler S., Zargar K., Schmidt A.C., Saltikov C., Seifert J., Schlomann M. Arch. Microbiol. 194:623-635(2012) · UniProtKB (77) |
| Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo. Kleiman R.J., Chapin D.S., Christoffersen C., Freeman J., Fonseca K.R., Geoghegan K.F., Grimwood S., Guanowsky V., Hajos M., Harms J.F. et al. J. Pharmacol. Exp. Ther. 341:396-409(2012) · Mapped (2) |
| The CD3-zeta chimeric antigen receptor overcomes TCR Hypo-responsiveness of human terminal late-stage T cells. Rappl G., Riet T., Awerkiew S., Schmidt A., Hombach A.A., Pfister H., Abken H. PLoS ONE 7:e30713-e30713(2012) · Mapped (5) |
| Adenylylation control by intra- or intermolecular active-site obstruction in Fic proteins. Engel P., Goepfert A., Stanger F.V., Harms A., Schmidt A., Schirmer T., Dehio C. Nature 482:107-110(2012) · UniProtKB (5) |
| Requirements for efficient correction of DeltaF508 CFTR revealed by analyses of evolved sequences. Mendoza J.L., Schmidt A., Li Q., Nuvaga E., Barrett T., Bridges R.J., Feranchak A.P., Brautigam C.A., Thomas P.J. Cell 148:164-174(2012) · Mapped (1) |
| Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury. Tekabe Y., Luma J., Li Q., Schmidt A.M., Ramasamy R., Johnson L.L. JACC Cardiovasc Imaging 5:59-67(2012) · Mapped (20) |
| Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia. Pfeifer H., Lange T., Wystub S., Wassmann B., Maier J., Binckebanck A., Giagounidis A., Stelljes M., Schmalzing M., Duhrsen U. et al. Leukemia 26:1475-1481(2012) · Mapped (28) |
| The GAG deletion in Tor1A (DYT1) is a rare cause of complex musician's dystonia. Schmidt A., Altenmuller E., Jabusch H.C., Lee A., Wiegers K., Klein C., Lohmann K. Parkinsonism Relat. Disord. 18:690-691(2012) · Mapped (3) |
| Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Ramasamy R., Yan S.F., Schmidt A.M. Ann. N. Y. Acad. Sci. 1243:88-102(2011) · Mapped (36) |
| Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. Cao P., Tu L.H., Abedini A., Levsh O., Akter R., Patsalo V., Schmidt A.M., Raleigh D.P. J. Mol. Biol. 421:282-295(2012) · Mapped (1) |
| RAGE mediates vascular injury and inflammation after global cerebral ischemia. Kamide T., Kitao Y., Takeichi T., Okada A., Mohri H., Schmidt A.M., Kawano T., Munesue S., Yamamoto Y., Yamamoto H. et al. Neurochem. Int. 60:220-228(2012) · Mapped (20) |